Pharma Pricing & Market Access Outlook Europe

Event contact first name
Event contact last name
Event contact telephone number
The 8th Annual Pharma Pricing and Market Access Outlook World Europe is the world?s largest gathering of pharmaceutical pricing, market access and reimbursement professionals regularly attracting a high attendance. It is a two day strategic conference addressing the critical policy issues in developing the optimum pricing strategy for pharmaceutical products. Reasons to attend: How the policy challenges in market access will effect you How to produce an optimum pricing strategy for pharma products How HTA practice effects the markets they are working in How innovative pricing and risk sharing models between industry and payers have changed Keynote speakers: Professor David Haslam , Chairman, NICE Adam Pilch , Head of Market Access, TEVA Thomas Mueller , Head of Pharmaceuticals, G-BA Germany Professor Lise Rochaix , Member of the Board, HAS, France Saira Jan, Director, Clinical Pharmacy Program Management, BCBS Dr Paolo Daniele Siviero, Head of Economic Strategy and Pharmaceutical Policy, AIFA, Italy

Partner Voices

Until recently, the opportunity to have a celebrity attend an event, attach themselves to a name-brand or endorse a certain product or idea was untouchable. The thought of paying a person to promote a product was seen as something only Fortune 500 companies could afford. Social media has changed all that with brands and businesses utilizing celebrity influencers to connect directly with their demographics and increase sales and profits.